How GPCR genetic variants shape psychiatric drug response - Hauser on pharmacogenomics, the iPSYCH biobank To answer this, his work integrates GPCR molecular pharmacology with computational biology, population genetics, and pharmacoepidemiology, drawing on Denmark's iPSYCH biobank - a cohort of 100,000 genotyped Psychiatry in Roskilde working with the UK Biobank and other large-scale population cohorts. Alexander has a big interest in the integration of large biomedical data in genomics, structural biology

Prior to Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences Between 1992 to 1995 he led contract research efforts at Biosym Technologies to develop and apply computational

fascinating career journeys, groundbreaking discoveries, and impactful contributions of experts in GPCR biology GPCR Podcast features leading scientists, innovators, and biotech professionals whose work is advancing We discuss breakthrough discoveries, career paths in pharmacology and molecular biology, and how each If you’re working on exciting GPCR-related research — from structural biology to drug discovery — we’ to connect, exchange, and collaborate to improve human health through a better understanding of GPCR biology

Terry Hebert explains why studying GPCRs in HEK293 cells misses critical biology — and how iPSC-derived His lab develops BRET- and FRET-based biosensors that produce different conformational outputs depending His research centers on GPCR signaling networks, biosensor development, and the role of cellular context Trained in microbiology and ion channel biology at the University of Toronto, he transitioned to GPCRs His lab develops resonance energy transfer-based biosensors and applies them in induced pluripotent stem

Les Houches, France in 1979 where he was exposed for the first time to the nascent field of membrane biophysics Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay platforms, including FTIR and Raman microprobe spectroscopy to study micro-quantities applications included “targeted photo-crosslinking,” and more recently, the parallel development of bioorthogonal

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before expertise over the past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence

My project involved the development of FRET/BRET -based GPCR conformational biosensors, which can be

Graham Ladds Graham studied Biochemistry at the University of Birmingham before completing a Ph.D. in

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from

After earning her undergraduate degree in biochemistry from the University of Michigan, she deferred

joined in April 2020, following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology. Katarzyna handles submissions in structural biology, biophysics and biochemistry, with a particular focus

Sudha Shenoy is currently an Associate Professor in Medicine & Cell Biology in the Division of Cardiovascular

GPCRs are among the most powerful and complex targets in biomedical research. Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of Bordeaux and an MS in biomedical business management from the Grenoble School of Management. Internalization is a core—but often overlooked—dimension of GPCR biology.

Ilana uses chemical biology-based methods to study the regulation and protein-protein interactions of Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and

Before returning to academia, she co-founded two GPCR-focused biotechs with Heidi Hamm - CUE Biotech and Caden Biosciences - developing G-protein C-terminal mini-gene peptide tools that became widely adopted Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success Gilchrist completed her Ph.D. in Biomedical Sciences / Immunology at the University of Connecticut and , Caden Biosciences , and MyGenomeRx in addition to being a consultant for over a decade.

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University

There, I completed a PhD in biochemistry exploring the non-canonical functions and possible novel mechanisms Badr recounting his journey from struggling with math in an engineering physics degree to excelling in biology and obtaining a Master’s degree in biochemistry. Philip Woozab’s, focusing on bacterial secretion systems, GPCRs, and bioinformatics.

Adriano Marchese Adriano Marchese is a Professor of Biochemistry at the Medical College of Wisconsin.

tissue-specific engagement Who should listen Navigated complex datasets where interpretation depended on biological His group develops imaging and chemical biology tools to reveal how GLP-1 and GIP receptors operate within David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Unlock

co-founder of Propel Careers, has spent more than a decade coaching PhDs and postdocs and recruiting for biotech CEO and co-founder of Propel Careers, a Boston-based firm that coaches scientists and recruits for biotech and research institutions on resumes, negotiation, informational interviewing, and the mechanics of biotech Function over title Job titles in biotech are often creative and inconsistent — a medical science liaison scientists undervalue 14:16 The informational interview — permission granted 23:57 The COVID shift in biotech

His lab combines cell and molecular biology with animal pharmacology to identify new signaling regulators

Structural biologist Qing Fan describes a decade of GABA-B receptor research at Columbia - from obligate ABOUT THE GUEST Qing Fan is an associate professor of pharmacology and pathology and cell biology at A structural biologist by training, her research focuses on the three-dimensional architecture of class cross-disciplinary collaboration, to connect structural findings to receptor function and disease-relevant biology Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit

GPCR Retreat — an immersive event uniting scientists, biotech leaders, and innovators in GPCR research

FB is recognized for her expertise and pioneering works in the field of biological and pathological functions

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

culture of normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker interest in science originated from a young age and his desire to gain more knowledge about cancer biology They also shared their personal experiences and interest in the field of biology. proposed further exploration of dosage and length of treatment in a mouse model and suggested using a biosensor-based

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Bianca Plouffe obtained her B.Sc. in Biochemistry in 2003 from Université de Sherbrooke (Qc, Canada). As part of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology